http://www.envita.com/ - The Stage 4 Prostate Cancer unfolded from the initial location and it's referred to as a metastasis. it's necessary that we want to unravel this drawback.

1. A Background on Prostate Cancer and Other
Stage 4 Cancer Protocols
Prostate cancert in the early stage, has, for some time, been treated with surgery (in
some cases drastic), radiation, chemotherapy, and medications that eliminate or block
testosterone to increase survival.
In fact, Davinci Robotic laparoscopic surgery has become enormously popular, but
justifiably can only be recommended for early state prostate cancers. With late stage or
stage 4 prostate cancer we typically witness more of the same as far as radiation and
chemo are concerned, however, it is common to see adjunct forms of these treatments
if the patient had grown refractory (i.e. lackluster response) to the first regimen. As
metastasis begins, these treatments are proven to be ineffective and more likely to do
more harm than good.
Advancing to the forefront, Immunotherapy for stage 4 prostate cancer - a dramatic
new way of targeting metastasis and dueling with the primary site of the cancer all at
one time. Pertinent data clearly reflects that as tumors and cancer stages progress so
do immune blocking mechanisms conjured (up regulated) by cancers to self-arm.
Advanced Stage 4 Prostate Cancer Treatment
The field of cancer immunology spans more than 30 years old and has developed
quickly, particularly over the most recent decade. Immunotherapy, the use of the

2. stimulated immune system to target disease, has branched out into multiple subsets
including immune system growth factors, monoclonal antibodies, cellular therapies, and
apparent combinations of two or more of these strategies. Recent noteworthy advances
in adoptive immunotherapy (focused on the expansion of specific disease-fighting white
blood cells and their infusion into patients) have brokered breakthrough discoveries that
have already been tapped and will continue to genuinely impact stage 4 cancer
treatment.
The Cells That Stage 4 Prostate Cancers Fear
It is widespread common knowledge among physicians and scientists in the field that
three types of white blood cells can be activated by the immune system to defeat
prostate and other stage 4 cancer cells: cytotoxic T lymphocytes (CTLs), natural killer
cells (NKs), and natural killer T cells (NKTs). These aforementioned cells can be found
circulating in the body in miniscule amounts; however, they are heralded as a major
first-line immune system defense against stage 4 prostate cancer.
Envita Leads the Field in Stage 4 Prostate Cancer Immunotherapy
A plethora of published studies have demonstrated the effects of adoptive immune
therapy in stage 4 prostate cancer patients. Envita's renowned medical team parsed the
most provocative of these studies and focused on the strengths and weaknesses of
each. Their data established a protocol that incorporates only the foremost procedures
for the expansion and application of cells as a powerful immunotherapy. Our protocols
emanate from the most recent published research in the field, from a multitude of the
most prestigious hospitals and universities in this nation and on a global scale Yet, our
immunology treatment has been tailored to deal specifically with prostate cancer and
stage 4 prostate cancer patients' immune systems.
AAIT for Stage 4 Prostate Cancer - Available at Envita Mexico
The activated natural killer cells in Envita's AAIT stage 4 cancer vaccine are erstwhile
more effective in the realm of tumor obliteration than other similar treatments from over
the globe. Lauded by scientific research and clinical results, Envita's AAIT offers a
powerful option for stage 4 prostate cancer patients who seek to marginalize their

3. disease while keeping their immune system intact. If you have any inquiries concerning
Envita’s AAIT stage 4 prostate cancer vaccine, please consult with our premier
assembly of physicians and/or patient educators. This particular stage 4 prostate
cancer therapy is available in Envita Mexico's international cancer center.